Le Lézard
Classified in: Health, Science and technology
Subject: Conference

Vedanta Biosciences to Present at Upcoming Investor Conferences


Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that members of its executive team will participate at the following investor conferences:

Wells Fargo Virtual Private Biotech Symposium
Date: Monday, May 6, 2024
Virtual 1x1 meetings only

The Citizens JMP Life Sciences Conference
Dates: May 13-14, 2024
Presentation: Tuesday, May 14 at 12:30 p.m. ET
Location: New York Hilton Midtown, New York, NY

About Vedanta Biosciences

Vedanta Biosciences is a clinical-stage biopharmaceutical company developing medicines for the treatment of gastrointestinal diseases. The company's lead assets are potential first-in-class oral therapies ? VE303, soon to begin a Phase 3 registrational trial for prevention of recurrent C. difficile infection, and VE202, in a Phase 2 trial for treatment of ulcerative colitis. Vedanta's pipeline has been built using the company's industry-leading product engine for the development of therapies based on defined consortia of bacteria grown from pure clonal cell banks. The product engine, supported by broad foundational intellectual property, includes one of the largest libraries of bacteria isolated from the human microbiome, vast clinical datasets, proprietary capabilities in consortium design, and end-to-end CGMP manufacturing capabilities at commercial launch scale.


These press releases may also interest you

at 14:00
Marine Biotechnology Market size is set to grow by USD 4.71 billion from 2024-2028, Increase in demand for biofuel to boost the market growth, Technavio
The global marine biotechnology market size is estimated to grow by USD 4.71 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 9.83% during the forecast period. Increase in demand for biofuel is...

at 13:45
InventHelp Inventor Develops Specially Designed Pillow (HOF-533)
"For more than ten years, I had not slept more than two hours per night. I decided I had to make a change," said an inventor, from Conroe, Texas, "so I wanted to sleep with ear pods and listen to nature sounds. However, it was very painful to my ears...

at 13:44
Medical College of Wisconsin Set to Lead Key Initiative as Part of EDA Tech Hub Phase 2 Funding
The U.S. Economic Development Administration (EDA) has awarded $49 million to the Wisconsin BioHealth Tech Hub (Tech Hub), a transformative initiative to make Wisconsin a national leader in personalized medicine by accelerating biomedical innovation,...

at 13:10
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on July 1, 2024, the...

at 13:05
Introducing SPN1 - The Ultimate Tremor-Assistive Spoon Launching Soon
Pletho, a recently launched assistive-tech startup, is proud to announce the upcoming launch of SPN1. Designed to empower individuals with fine motor control and dexterity challenges, SPN1 promises to revolutionize mealtime experiences for people...

at 13:02
AARP Awards Grants to 4 Organizations in Mississippi as Part of Nationwide Program to Make Communities More Livable
AARP has announced 4 organizations throughout Mississippi will receive 2024 Community Challenge grants ? part of AARP's largest Investment in communities to date with $3.8 million awarded among 343 organizations nationwide. Grantees will implement...

More news about Health...


News published on and distributed by: